However, adoptive transfer of purified CD8+ T cells harvested from MM51R-treated B16gp33 melanoma-bearing mice into naive mice provided better protection against parental B16 tumor implantation compared to CTLs taken from WT or G mutant-treated mice. Here, CD8A is linked to melanoma.